Six Specialty DSOs and Their Current Network Scale in 2026

Bypaulgruensfelder
Becker’s Dental Review March 31, 2026
Read Full Article →
AI-Generated Summary

Becker’s Dental Review provides a current-state snapshot of six specialty-focused dental DSOs and MSOs as of early 2026. Allied OMS operates more than 30 offices across 12 states; Beacon Oral Specialists has reached 106 locations in 12 states; Epic4 Specialty Partners supports 61 practices in 16 states; Smile Doctors runs more than 580 orthodontic offices in 36 states; Specialized Dental Partners has exceeded 275 offices in 36 states; and Specialty1 Partners operates more than 220 offices in 28 states. The piece illustrates the scale specialty DSO platforms have reached and the continued geographic diversification of dentistry’s consolidation wave across oral surgery, orthodontics, and related specialties.

Why It Matters

Specialty DSO networks have grown to a scale where geographic reach and service-line breadth are now standard competitive baselines — not differentiators. For operators, investors, and advisors in dental and specialty care, this snapshot provides a quick benchmark for network size, multi-state expansion, and the pace of consolidation across key specialties.

specialty DSO dental MSO oral surgery orthodontics DSO network growth dental consolidation PE-backed dental

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Similar Posts

  • Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics

    Bypaulgruensfelder

    Four major forces are reshaping DSO growth in 2026: private equity resurging in oral surgery (up 9.1% in PE deals), medical-dental integration expanding through health system partnerships, AI adoption at scale across patient communication and operations, and salivary diagnostics emerging as a clinical frontier. For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating — and what capabilities will separate market leaders from laggards through 2027.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Health System Leaders on Costs, Innovation, and the Affordability Challenge

    Bypaulgruensfelder

    Top U.S. health system executives say affordability and cost pressure now sit at the center of nearly every strategic decision. In a Chief Healthcare Executive roundtable, leaders including Hackensack Meridian Health CEO Robert Garrett argued that systems must shift from treating illness toward preventing chronic disease and keeping communities healthy. Panelists framed innovation, particularly AI, as a double-edged force: either an ingredient in solving the affordability challenge or a threat to traditional business models. The group sees significant potential for new technology to transform operations and care delivery, while cautioning that disruption is inevitable and that executives must actively manage change rather than react to it.